title: Taking the sub Q route in anemia management.
authors.forename: M
authors.initials: M
authors.lastname: Licht
authors.forename: L
authors.initials: L
authors.lastname: Eastman
authors.forename: S
authors.initials: S
authors.lastname: Kauffman
authors.forename: P
authors.initials: P
authors.lastname: Crooks
authors.forename: H
authors.initials: H
authors.lastname: Yeoh
mesh_terms: D000740:Anemia / Q000188:drug therapy*; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000008:administration & dosage* / Q000592:standards / Q000627:therapeutic use*; D006397:Hematinics / Q000008:administration & dosage* / Q000592:standards / Q000627:therapeutic use*; D006801:Humans; D007279:Injections, Subcutaneous / Q000592:standards*; D011994:Recombinant Proteins
chemical_list: D006397:Hematinics; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa